NORLUX Neuro-Oncology Laboratory
NORLUX is an interdisciplinary preclinical research group dedicated to exploring brain tumor biology towards identification of innovative biomarkers and novel treatment options for patients.
activities
We are dedicated to advancing treatment options for malignant brain tumors, with a specific focus on diffuse gliomas. With a radically translational approach to our research, we employ patient samples and innovative patient-derived preclinical model systems that faithfully reproduce the patient tumor. In our research, we investigate the cellular and molecular basis of gliomas, we explore their capacity to invade healthy brain tissue and escape therapy. Our overarching goal is to reveal novel therapeutic targets and identify reliable biomarkers of treatment responses.
SCIENTIFIC AREAS OF INTEREST AND ACTIVITIES
- Advanced brain tumor patient avatars for preclinical investigations and treatment efficacy studies
- Personalized medicine and pharmacogenomics
- Tumor heterogeneity at cellular, multi-omics and functional levels
- Tumor plasticity and resistance mechanisms
- Tumor-microenvironment interactions and immuno-oncology
Golebiewska
Patient cohorts and consortia
Funding Support
Please note that we are not currently recruiting for any Clinical Trials.
Projects & clinical trials
Featured team members
-
Hamed
Allahverdi PhD Student -
Claire
Dording Laboratory Technician -
Luca
Ermini Scientist -
Anna
Golebiewska Group Leader -
Iryna
Krokhmal Laboratory Technician -
Anuja
Lipsa Postdoctoral Fellow -
Pilar Maria
Moreno Sanchez PhD Student -
Bakhtiyor
Nosirov Postdoctoral Fellow
Scientific publications
-
Mapping extrachromosomal DNA amplifications during cancer progression – 14/10/2024
-
Patient-based multilevel transcriptome exploration highlights relevant chemokines and chemokine receptor axes in glioblastoma – 30/09/2024
-
Protocol using ex vivo mouse brain slice culture mimicking in vivo conditions to study tumor growth and cell motility of glioblastoma cells – 18/10/2024
-
Challenging the status quo to improve the translational potential of preclinical oncology studies – 07/10/2024
-
Deep intravital brain tumor imaging enabled by tailored three-photon microscopy and analysis – 10/09/2024
-
PARK7/DJ-1 deficiency impairs microglial activation in response to LPS-induced inflammation – 16/07/2024
-
AllergoOncology – 01/01/2024
-
Most accurate mutations in SARS-CoV-2 genomes identified in Uzbek patients show novel amino acid changes – 31/05/2024
-
Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts – 02/04/2024
-
Plasticity of repetitive sequences demonstrated by the complete mitochondrial genome of Eucalyptus camaldulensis – 27/03/2024
Related News
Job vacancies
There are no jobs matching this page at the moment. You can view all jobs via the button below.